Vaccination against parasites – status quo and the way forward. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Joachim, Anja
• Is Part Of: Porcine health management. Volume 2:Issue 1(2016)
• Page Start: 1
• Page End: 5
• Publication Date: 2016-12
• Subjects: Swine -- Vaccine -- Immunity -- Nematodes -- Protozoa; Swine -- Health -- Periodicals; Swine -- Diseases -- Treatment -- Periodicals; 636.4089
• DOI: 10.1186/s40813-016-0047-9
• Languages: English
• ISSNs: 2055-5660

Abstract

Abstract Although vaccination against various pathogens is integral to health management of swine, vaccines against parasites have not yet been commercialized for the use in pigs. The incentive to develop and commercialize anti-parasitic vaccines in swine are twofold; on the one hand parasitic diseases which are economically important, such as ascarosis and neonatal coccidiosis, could be controlled in a sustainable manner; on the other hand, the transmission of zoonotic parasites, such asToxoplasma gondii or Cysticercus cellulosae, could be effectively interrupted. Although experimental research indicates that vaccination against a number of porcine parasites is feasible, development and commercialization of potential vaccines so far has been very slow, as our knowledge on the host-parasite interplay in porcine parasitic infections is still very limited. In the light of growing concerns regarding consumer health and antiparasitic drug resistance, however, it is timely to re-direct R&D efforts to the development of biological control options.